Djokovic’s crusade: he bought 80% of a Danish pharmaceutical company to develop treatments against covid

Djokovic’s crusade: he bought 80% of a Danish pharmaceutical company to develop treatments against covid

The Serb invested in the biotech company QuantBioRes in June 2020. The amount he contributed to the project is unknown

Three days after being deported from Australia for not being vaccinated against covid, it has become known that Novak Djokovic has an 80% stake in QuantBioRes, a Danish biotech company whose goal is to develop a medical treatment to counter coronavirus. This was stated to Reuters by the company’s executive director, Ivan Loncarevic . According to Loncarevic himself, the Serbian tennis player made the investment in June 2020, but did not want to disclose the amount of money contributed.

QuantBioRes has about 11 researchers working in Denmark, Australia and Slovenia, according to Loncarevic, who emphasized that they were working on a treatment, not a vaccine. The company is developing a peptide that stops the coronavirus from infecting the human cell and hopes to launch clinical trials in Britain this summer.

A Djokovic spokesman declined to speak on the matter. And it is that the tennis number one has fueled the global debate on the rights of people who choose not to be vaccinated, after he was deported from Australia on Sunday night.

Samuel Edwards
Samuel Edwards is the name you must have heard many times while reading reports related to Finance, that's what he is good at. From Major Investments to Stock Market Updates, he got 'em all. Be ready to blow your mind by the mind-blowing reports of Finance World from Samuel Edwards.